Yasuhiko Tomino

Q: What Schools Are Affiliated With Yasuhiko Tomino

Yasuhiko Tomino is affiliated with the following schools: Hokkaido University, Tokai University, University of Tokyo, Juntendo University, Osaka University, Kyoto University

Yasuhiko Tomino's AcademicInfluence.com Rankings

Yasuhiko Tomino

Computer Science

#5481

World Rank

#5789

Historical Rank

Machine Learning

#1477

World Rank

#1499

Historical Rank

Artificial Intelligence

#1710

World Rank

#1742

Historical Rank

Database

#2634

World Rank

#2756

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Yasuhiko Tomino's Degrees

PhD Computer Science University of Tokyo
Masters Computer Science University of Tokyo
Bachelors Computer Science University of Tokyo

Similar Degrees You Can Earn

Why Is Yasuhiko Tomino Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Yasuhiko Tomino's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Revised equations for estimated GFR from serum creatinine in Japan. (2009) (4940)
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. (2009) (1022)
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. (2009) (848)
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. (2009) (398)
Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling (2006) (392)
mRNA Expression of Growth Factors in Glomeruli From Diabetic Rats (1993) (328)
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. (2008) (256)
A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study (2009) (215)
Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. (2012) (206)
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial. (2018) (205)
The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension (2009) (199)
MAP‐LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis (2003) (196)
IgA nephropathy (2016) (178)
Podocyte Migration during Nephrotic Syndrome Requires a Coordinated Interplay between Cathepsin L and α3 Integrin* (2004) (172)
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. (2010) (171)
Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes. (2007) (169)
Toll-like receptor 9 affects severity of IgA nephropathy. (2008) (158)
A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. (2006) (157)
ECM Gene Expression and Its Modulation by Insulin in Diabetic Rats (1992) (153)
Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. (2004) (149)
A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy (2014) (146)
Effect of a Specific Endothelin Receptor A Antagonist on mRNA Levels for Extracellular Matrix Components and Growth Factors in Diabetic Glomeruli (1995) (145)
Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis. (1996) (144)
Urinary levels of monocyte chemoattractant protein‐1 (MCP‐1) and interleukin‐8 (IL‐8), and renal injuries in patients with type 2 diabetic nephropathy (2002) (134)
Effect of a specific endothelin A receptor antagonist on murine lupus nephritis. (1995) (125)
Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin (2012) (120)
FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells. (2002) (118)
Cytokines Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes* (2013) (116)
Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes. (2006) (111)
A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases (2014) (110)
Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. (1982) (109)
Gene expression for endothelins and their receptors in glomeruli of diabetic rats. (1993) (108)
Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. (2004) (105)
Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy (2015) (100)
A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity (2009) (99)
Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120 (2018) (94)
Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice. (2007) (92)
Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice. (2004) (89)
Growth factor gene expression in kidney of murine polycystic kidney disease. (1993) (88)
A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease. (2013) (85)
Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version (2003) (82)
Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice. (2011) (81)
Down-regulation of core 1 β1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1 (2010) (81)
Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function (2011) (80)
IgA nephropathy: clinicopathology and immunopathology. (1978) (78)
Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy (2014) (77)
Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. (1995) (76)
IgA-specific helper activity of T alpha cells in human peripheral blood. (1981) (75)
Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection (1998) (75)
Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension--a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) study. (2004) (74)
Detection of serum IL-6 in patients with diabetic nephropathy. (1994) (74)
Toll-Like Receptor 9 Stimulation Induces Aberrant Expression of a Proliferation-Inducing Ligand by Tonsillar Germinal Center B Cells in IgA Nephropathy. (2017) (73)
Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study (2011) (73)
Immunoglobulin A1 and IgA nephropathy. (1981) (72)
Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a Type 2 diabetes model: is Zn-alpha2 glycoprotein-1 a candidate gene for obesity? (2003) (71)
Increase of IgA specific helper T alpha cells in patients with IgA nephropathy. (1982) (71)
Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. (2005) (70)
Relationship between Polymorphism in the Angiotensinogen, Angiotensin-Converting Enzyme or Angiotensin II Receptor and Renal Progression in Japanese NIDDM Patients (1999) (70)
Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease (2009) (70)
Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial (2009) (69)
The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study (2014) (69)
Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells. (2007) (67)
Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice. (2014) (66)
A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004. (2005) (66)
Serum Cystatin C Is a More Sensitive Marker of Glomerular Function than Serum Creatinine (2002) (65)
Transcriptional activation of matrix genes by transforming growth factor beta 1 in mesangial cells. (1993) (65)
Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy. (2012) (65)
Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis. (1996) (65)
Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice. (2004) (64)
Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomeruli from diabetic rats. (1994) (64)
The role of podocytes in proteinuria (2007) (64)
Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes. (2002) (63)
Mutations in CLCN5 chloride channel in Japanese patients with low molecular weight proteinuria. (1998) (63)
Levels of urinary matrix metalloproteinase‐9 (MMP‐9) and renal injuries in patients with type 2 diabetic nephropathy (2004) (62)
Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy (2014) (62)
Cross-reactivity of IgA antibodies between renal mesangial areas and nuclei of tonsillar cells in patients with IgA nephropathy. (1983) (61)
Glomerular changes in the KK‐Ay/Ta mouse: A possible model for human type 2 diabetic nephropathy (2006) (60)
Mechanisms and interventions in peritoneal fibrosis (2012) (57)
Modified open renal biopsy: results in 934 patients. (1987) (55)
Renal expression of mRNAs for endothelin-1, endothelin-3 and endothelin receptors in NZB/W F1 mice. (1993) (55)
Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy (2003) (55)
Risk stratification for progression of IgA nephropathy using a decision tree induction algorithm (2008) (54)
Primary intracranial yolk sac tumor. Immunofluorescent demonstration of alpha‐F etoprotein synthesis (1976) (54)
Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-beta in experimental glomerular sclerosis. (1993) (54)
Pioglitazone attenuates TGF‐β1‐induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator‐activated receptor (PPAR)γ (2005) (53)
Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation. (2006) (53)
Tonsillar TLR9 expression and efficacy of tonsillectomy with steroid pulse therapy in IgA nephropathy patients. (2012) (53)
Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function. (2008) (52)
Increased endothelin and endothelin receptor mRNA expression in polycystic kidneys of cpk mice. (1993) (52)
Pre-Existing Glomerular Immune Complexes Induce Polymorphonuclear Cell Recruitment Through an Fc Receptor-Dependent Respiratory Burst: Potential Role in the Perpetuation of Immune Nephritis 1 (2003) (51)
Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte (2010) (49)
Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene. (1999) (49)
Effect of Exercise on Kidney Function, Oxidative Stress, and Inflammation in Type 2 Diabetic KK-Ay Mice (2012) (48)
Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis. (1993) (48)
Epstein-Barr virus detection in kidney biopsy specimens correlates with glomerular mesangial injury. (1998) (48)
Reactive oxygen species-mediated signaling pathways in angiotensin II-induced MCP-1 expression of proximal tubular cells. (2005) (48)
Susceptibility to T Cell-Mediated Injury in Immune Complex Disease Is Linked to Local Activation of Renin-Angiotensin System: The Role of NF-AT Pathway1 (2002) (48)
Dendrin Location in Podocytes Is Associated with Disease Progression in Animal and Human Glomerulopathy (2011) (48)
Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy (2009) (48)
Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. (2002) (48)
Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: insights from animal models. (2008) (48)
Modulation of basement membrane component gene expression in glomeruli of aminonucleoside nephrosis. (1991) (47)
Blockade of TGF-β Signaling in T Cells Prevents the Development of Experimental Glomerulonephritis1 (2001) (47)
Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis. (2002) (47)
Detection of immune complexes in polymorphonuclear leukocytes by double immunofluorescence in patients with IgA nephropathy. (1982) (47)
Development of a model of early-onset IgA nephropathy. (2012) (47)
Nationwide survey on current treatments for IgA nephropathy in Japan (2013) (47)
Significance of Urinary Full-Length and Ectodomain Forms of Megalin in Patients With Type 2 Diabetes (2012) (46)
Angiotensin II, the immune system and renal diseases: another road for RAS? (2003) (46)
Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats. (2007) (45)
Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy. (1996) (45)
The development of focal segmental glomerulosclerosis in Masugi nephritis is based on progressive podocyte damage (1996) (44)
Podocyte Injury Predicts Prognosis in Patients with IgA Nephropathy Using a Small Amount of Renal Biopsy Tissue (2001) (44)
Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy (2003) (43)
Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system. (2011) (43)
In vivo alteration of antibody production in patients with IgA nephropathy. (1984) (43)
The Prevalence and Management of Diabetic Nephropathy in Asia (2015) (43)
Extracellular matrix component mRNA expression in glomeruli in experimental focal glomerulosclerosis. (1993) (43)
Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy (2000) (42)
Relationship between Abdominal Fat Accumulation and Insulin Resistance in Hemodialysis Patients (2008) (42)
Protein gene product 9.5 is selectively localized in parietal epithelial cells of Bowman's capsule in the rat kidney. (2000) (42)
IgA antibodies to dietary antigens and lectin-binding IgA in sera from Italian, Australian, and Japanese IgA nephropathy patients. (1991) (42)
Diffuse proliferative glomerulonephritis with hepatitis C virus-like particles in paramesangial dense deposits in a patient with chronic hepatitis C virus hepatitis. (1993) (42)
Scleritis and IgA nephropathy. (1980) (42)
Mast Cell-Mediated Remodeling and Fibrinolytic Activity Protect against Fatal Glomerulonephritis1 (2006) (42)
Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli. (1994) (42)
Gene expression profile in diabetic KK/Ta mice. (2003) (42)
Urinary levels of interleukin-6 and disease activity in patients with IgA nephropathy. (1991) (41)
Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis (2017) (41)
Cathepsin D in Podocytes Is Important in the Pathogenesis of Proteinuria and CKD. (2016) (41)
Asian multicenter trials on urinary type IV collagen in patients with diabetic nephropathy (2001) (40)
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data (2014) (40)
A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey) (2004) (39)
Pathological Role of Tonsillar B Cells in IgA Nephropathy (2011) (39)
Immunofluo rescent demonstration of alpha‐fetoprotein and other plasma proteins in yolk sac tumor (1976) (39)
Specificity of eluted antibody from renal tissues of patients with IgA nephropathy. (1982) (38)
Insertion/deletion polymorphism in ACE gene is not associated with renal progression in Japanese patients with IgA nephropathy. (2000) (38)
Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients. (2008) (38)
A case of IgA nephropathy associated with adeno- and herpes simplex viruses. (1987) (38)
Lessons From the KK-Ay Mouse, a Spontaneous Animal Model for the Treatment of Human Type 2 Diabetic Nephropathy (2012) (38)
Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress. (2006) (38)
Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration. (2008) (37)
Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes. (2012) (37)
Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy (2017) (37)
Serum cystatin C. (2001) (37)
Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients. (2002) (37)
Low protein diet blunts the rise in glomerular gene expression in focal glomerulosclerosis. (1994) (37)
Modulation of glomerular endothelin and endothelin receptor gene expression in aminonucleoside-induced nephrosis. (1995) (36)
Notch2 activation ameliorates nephrosis (2014) (36)
The mucosa-bone-marrow axis in IgA nephropathy. (2007) (36)
A case of acute tubulointerstitial nephritis and uveitis syndrome with a dramatic response to corticosteroid therapy. (1989) (36)
T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy (2008) (36)
Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis (2011) (35)
Peritoneal Fibrosis Intervention (2007) (35)
Significance of urinary type IV collagen in patients with diabetic nephropathy using a highly sensitive one‐step sandwich enzyme immunoassay (1997) (35)
Novel Biomarkers for the Progression of Diabetic Nephropathy: Soluble TNF Receptors (2013) (35)
Mindin: a novel marker for podocyte injury in diabetic nephropathy. (2011) (35)
IgA nephropathy: lessons from an animal model, the ddY mouse. (2008) (35)
Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy (2015) (35)
High incidence of renal failure in patients with aortic aneurysms. (2007) (34)
Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice. (2009) (34)
Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan. (2015) (34)
Rapamycin inhibits transforming growth factor β-induced peritoneal angiogenesis by blocking the secondary hypoxic response (2012) (34)
Three-dimensional analysis of the whole mesangium in the rat. (1996) (34)
Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy (2015) (34)
Alterations in proteoglycan components and histopathology of the peritoneum in uraemic and peritoneal dialysis (PD) patients. (2009) (33)
Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients. (2016) (33)
Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy (2013) (33)
Fine structure of the glomerular basement membrane of the rat kidney visualized by high-resolution scanning electron microscopy (1991) (33)
Effect of Combination Therapy with Angiotensin Receptor Blocker and 1,25-Dihydroxyvitamin D3 in Type 2 Diabetic Nephropathy in KK-Ay/Ta Mice (2010) (33)
Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. “Current status and perspective of CKD in Asia”: diversity and specificity among Asian countries (2009) (33)
Polymorphism in promoter region of Fcα receptor gene in patients with IgA nephropathy (2001) (33)
Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis. (1997) (33)
Urinary levels of interleukin‐8 (IL‐8) and disease activity in patients with IgA nephropathy (2001) (32)
Prediction of diagnosis of immunoglobulin a nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading (2008) (32)
Macrophage‐derived MT1‐MMP and increased MMP‐2 activity are associated with glomerular damage in crescentic glomerulonephritis (2000) (32)
Expression of intercellular adhesion molecule-1 and infiltration of lymphocytes in glomeruli of patients with IgA nephropathy. (1994) (32)
Effect of Steroid-Liposome on Immunohistopathology of IgA Nephropathy in ddY Mice (2001) (31)
Detection of Apoptotic Cells in Glomeruli of Patients with IgA Nephropathy (1998) (31)
Advances in Targeting Drug Delivery to Glomerular Mesangial Cells by Long Circulating Cationic Liposomes for the Treatment of Glomerulonephritis (2007) (31)
Follow‐up study on urinary type IV collagen in patients with early stage diabetic nephropathy (1998) (31)
Hypercomplementemia in adult patients with IgA nephropathy (2007) (31)
Effect of pitavastatin on type 2 diabetes mellitus nephropathy in KK-Ay/Ta mice. (2008) (30)
Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema (2013) (30)
Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease. (2008) (30)
Low Hemoglobin Levels and Hypo‐Responsiveness to Erythropoiesis‐Stimulating Agent Associated With Poor Survival in Incident Japanese Hemodialysis Patients (2014) (30)
Urinary levels of monocyte chemoattractant protein (MCP)‐1 and disease activity in patients with IgA nephropathy (1998) (30)
Metalloproteinase-9 mRNA Expression in Monocytes from Patients with Chronic Renal Failure (1998) (29)
Relationship between Mast Cells in the Tubulointerstitium and Prognosis of Patients with IgA Nephropathy (2001) (29)
Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography. (2012) (29)
IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1. (2007) (29)
Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes. (1997) (28)
Diagnosis and treatment of patients with IgA nephropathy in Japan (2016) (28)
Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice. (2003) (28)
Different Pathological Roles of Toll-Like Receptor 9 on Mucosal B Cells and Dendritic Cells in Murine IgA Nephropathy (2011) (28)
Association of the DD genotype and development of Japanese type 2 diabetic nephropathy. (2001) (28)
Detection of Cell Death of Cultured Mouse Mesangial Cells Induced by Oxidized Low-Density Lipoprotein (1999) (27)
β‐trace protein, a new marker of GFR, may predict the early prognostic stages of patients with type 2 diabetic nephropathy (2004) (27)
Effects of Oral Adsorbent AST-120 (Kremezin®) on Renal Function and Glomerular Injury in Early-Stage Renal Failure of Subtotal Nephrectomized Rats (2002) (27)
Long-Term Effects of the Oral Adsorbent, AST-120, in Patients with Chronic Renal Failure (2009) (27)
Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis (2011) (27)
Significance of Urinary Full-Length Megalin in Patients with IgA Nephropathy (2014) (27)
Serum IgA/C3 Ratio May Predict Diagnosis and Prognostic Grading in Patients with IgA Nephropathy (2002) (26)
FcγRIIa-131R allele and FcγRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy (2005) (26)
Serum cystatin C may predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy (2001) (26)
Effects of methylprednisolone on glomerular and medullary mRNA levels for extracellular matrices in puromycin aminonucleoside nephrosis. (1991) (26)
Development of Animal Models of Human IgA Nephropathy. (2014) (25)
Gene expression of growth-related proteins and ECM constituents in response to unilateral nephrectomy. (1992) (25)
AGE-RAGE interaction and oxidative stress in obesity-related renal dysfunction. (2011) (25)
Enhanced expression of membrane type-1 matrix metalloproteinase in mesangial proliferative glomerulonephritis. (1998) (25)
Increased steady-state levels of mRNA coding for extracellular matrix components in kidneys of NZB/W F1 mice. (1991) (25)
Pleiotropic effect of pyridoxamine on diabetic complications via CD36 expression in KK-Ay/Ta mice. (2009) (25)
Gene expression of metalloproteinases and their inhibitor in renal tissue of New Zealand black/white F1 mice. (1993) (25)
Effect of danazol on solubilization of immune deposits in patients with IgA nephropathy. (1984) (25)
Pravastatin Inhibits Carboxymethyllysine-Induced Monocyte Chemoattractant Protein 1 Expression in Podocytes via Prevention of Signalling Events (2007) (24)
Intravenous N-Acetylcysteine during Haemodialysis Reduces the Plasma Concentration of Homocysteine in Patients with End-Stage Renal Disease (2006) (24)
Oxidative metabolism of polymorphonuclear leukocytes (PMN) in patients with IgA nephropathy (1992) (24)
Alteration of growth-related proto-oncogene expression in diabetic glomeruli by a specific endothelin receptor A antagonist. (1996) (24)
Three cases of PR3-ANCA positive subacute endocarditis caused by attenuated bacteria (Propionibacterium, Gemella, and Bartonella) complicated with kidney injury (2011) (24)
Effect of AST-120 on Endothelial Dysfunction in Adenine-Induced Uremic Rats (2014) (24)
Altered expression of lymphocyte homing chemokines in the pathogenesis of IgA nephropathy. (2007) (23)
Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy. (2013) (23)
Adipose-derived mesenchymal stem cells transplantation facilitate experimental peritoneal fibrosis repair by suppressing epithelial–mesenchymal transition (2014) (23)
A patient with TSC1 germline mutation whose clinical phenotype was limited to lymphangioleiomyomatosis (2004) (23)
Altered glomerular steady-state levels of tumour necrosis factor-alpha mRNA during nephrotic and sclerotic phases of puromycin aminonucleoside nephrosis in rats. (1993) (23)
Quantitative evaluation and assessment of peritoneal morphologic changes in peritoneal dialysis patients. (2010) (23)
Effects Of The New Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Inhibitor Fluvastatin On Anti‐Oxidant Enzyme Activities And Renal Function In Streptozotocin‐Induced Diabetic Rats (2000) (23)
Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan (2008) (23)
Renal platelet-derived growth factor gene expression in NZB/W F1 mice with lupus and ddY mice with IgA nephropathy. (1992) (23)
Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia (2015) (23)
Production of hydrogen peroxide by neutrophilic polymorphonuclear leukocytes in patients with diabetic nephropathy (1993) (22)
Effects of 22-Oxa-Calcitriol on Podocyte Injury in Adriamycin-Induced Nephrosis (2011) (22)
Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA). (1987) (22)
Detection of glomerular sialic acids in patients with diabetic nephropathy. (1988) (22)
Combination Effects of Enalapril and Losartan on Lipid Peroxidation in the Kidneys of KK-Ay/Ta Mice (2009) (22)
IgA nephropathy. From molecules to men. (1999) (22)
Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis. (2008) (21)
Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP‐9 test kit (2004) (21)
Patient classification and outcome prediction in IgA nephropathy (2015) (21)
Beta-trace protein, a new marker of GFR, may predict the early prognostic stages of patients with type 2 diabetic nephropathy. (2004) (21)
Differentiation of bone marrow-derived cells into regenerated mesothelial cells in peritoneal remodeling using a peritoneal fibrosis mouse model (2012) (21)
T alpha cell subsets in human peripheral blood. (1985) (21)
Activation of complement by renal tissues from patients with IgA nephropathy. (1981) (21)
Proposal of remission criteria for IgA nephropathy (2014) (21)
Serum Concentration of Complement Components of the Lectin Pathway in Maintenance Hemodialysis Patients, and Relatively Higher Levels of L‐Ficolin and MASP‐2 in Mannose‐Binding Lectin Deficiency (2011) (21)
Chronic graft-versus-host autoimmune disease in Fc receptor gamma chain-deficient mice results in lipoprotein glomerulopathy. (2002) (21)
Endothelin-1 mRNA expression by peripheral blood monocytes in IgA nephropathy (1993) (21)
Clinical and laboratory characteristics that differentiate hereditary angioedema in 72 patients with angioedema. (2014) (20)
Effect of monoclonal antibody CD4 on glomerulonephritis of ddY mice, a spontaneous animal model of IgA nephropathy. (1993) (20)
Predictive Factors Associated with Left Ventricular Hypertrophy at Baseline and in the Follow‐Up Period in Non‐Diabetic Hemodialysis Patients (2011) (20)
A Case of Multicentric Castleman’s Disease Associated with Renal Amyloidosis and Pure Red Cell Aplasia (1998) (20)
Solubilization of intraglomerular deposits of IgG immune complexes by human sera or gamma-globulin in patients with lupus nephritis. (1984) (20)
M-cadherin, a candidate gene for type 2 diabetes and related phenotypes in a KK/Ta mouse model (2007) (20)
Complement system in IgA nephropathy. (1980) (20)
Chromosomal mapping of a quantitative trait locus for the development of albuminuria in diabetic KK/Ta mice. (2005) (20)
Measurement of sialic acid and acute phase reactant proteins in sera of patients with diabetic nephropathy. (1988) (20)
Implantation of Presternal Catheter Using Moncrief Technique: Aiming for Fewer Catheter-Related Complications (2001) (20)
Effect of Mizoribine on Glomerulonephritis of Early-Stage IgA Nephropathy in ddY Mice (1998) (19)
Usefulness of a Body Composition Analyzer, InBody 2.0, in Chronic Hemodialysis Patients (2006) (19)
Altered extracellular matrix component gene expression in murine polycystic kidney. (1995) (19)
Impaired solubilization of glomerular immune deposits by sera from patients with IgA nephropathy. (1983) (19)
Significance of combined cyclosporine−prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial (2013) (19)
Dietary Zinc Is a Key Environmental Modifier in the Progression of IgA Nephropathy (2014) (19)
Tensin is potentially involved in extracellular matrix production in mesangial cells (2004) (19)
Diagnosis and activity assessment of immunoglobulin A nephropathy: current perspectives on noninvasive testing with aberrantly glycosylated immunoglobulin A-related biomarkers (2014) (19)
Podocyte-specific deletion of Rac1 leads to aggravation of renal injury in STZ-induced diabetic mice. (2015) (19)
Homozygous C3 deficiency associated with IgA nephropathy. (1991) (19)
Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy (2017) (18)
Effects of Anti hypertensive Drugs on Antioxidant Enzyme Activities and Renal Function in Stroke-Prone Spontaneously Hypertensive Rats (1997) (18)
Detection of Urinary MCP-1 in Patients withDiabetic Nephropathy (1998) (18)
Involvement of p300 in TGF-β/Smad-Pathway-Mediated α2(I) Collagen Expression in Mouse Mesangial Cells (2003) (18)
Increase of Urinary Type IV Collagen in Normoalbuminuric Patients with Impaired Glucose Tolerance (1998) (18)
Asymmetric Dimethylarginine: A Novel Cardiovascular Risk Factor in End-Stage Renal Disease (2012) (18)
Predictive Factors Associated with the Period of Time before Initiation of Hemodialysis in CKD Stages 4 and 5 (2010) (18)
Effects of Automated Peritoneal Dialysis on Residual Urinary Volume (2000) (18)
Pathological Scenario with the Mannose-Binding Lectin in Patients with IgA Nephropathy (2012) (18)
Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy. (2011) (18)
Contribution of subcutaneous fat accumulation to insulin resistance and atherosclerosis in haemodialysis patients. (2009) (18)
Suppressive effects of iron overloading on vascular calcification in uremic rats (2014) (18)
A case of acute renal failure associated with type A acute hepatitis responds dramatically to plasmapheresis. (1986) (18)
Characterization of an acidic nuclear protein recognized by autoantibodies in sera from patients with IgA nephropathy. (1986) (17)
Urinary Excretion of Creatol, an In Vivo Biomarker of Hydroxyl Radical, in Patients with Chronic Renal Failure (2007) (17)
Effects of Acetate-Free Citrate Dialysate on Glycoxidation and Lipid Peroxidation Products in Hemodialysis Patients (2012) (17)
Antibiotics induce apoptosis of human peritoneal mesothelial cells (2003) (17)
[Revised criteria for the early diagnosis of diabetic nephropathy]. (2005) (17)
Impacts of Recombinant Human Erythropoietin Treatment During Predialysis Periods on the Progression of Chronic Kidney Disease in a Large‐Scale Cohort Study (Co‐JET study) (2014) (17)
A case of massive ascites due to lupus peritonitis with a dramatic response to steroid pulse therapy. (1989) (16)
Podocin is translocated to cytoplasm in puromycin aminonucleoside nephrosis rats and in poor-prognosis patients with IgA nephropathy (2015) (16)
Quantitative polymorphism of complement receptor type 1 (CR1) in patients undergoing haemodialysis. (2004) (16)
Immunofluorescent studies on S-protein in glomeruli from patients with IgA nephropathy. (1987) (16)
Impact of Body Mass Index on Progression of IgA Nephropathy Among Japanese Patients (2015) (16)
Effects of treatment with angiotensin‐converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats (1997) (16)
T lymphocyte subsets of the infiltrating cells in the salivary gland and kidney of a patient with Sjögren's syndrome associated with interstitial nephritis. (1985) (16)
Transient increase in proteinuria, poly-ubiquitylated proteins and ER stress markers in podocyte-specific autophagy-deficient mice following unilateral nephrectomy. (2014) (16)
Selective IgM deficiency: a case study. (1981) (16)
Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage (2014) (16)
Altered steady‐state levels of mrna coding for extracellular matrices in renal tissues of ddy mice, an animal model for iga nephropathy (1991) (16)
A case of renal sarcoidosis with complement activation via the lectin pathway. (2005) (15)
Dissociated Expression of Collagen Type IV Subchains in Diabetic Kidneys of KKAy Mice (1998) (15)
Evaluation of Long‐Term Combination Therapy With Peritoneal Dialysis and Hemodialysis (2017) (15)
Acute renal failure in a patient with severe malaria and dengue shock syndrome. (2008) (15)
Effects of a low-protein diet on glomerular endothelin family gene expression in experimental focal glomerular sclerosis. (1995) (15)
Accumulation of advanced glycation end products and beta 2-microglobulin in fibrotic thickening of the peritoneum in long-term peritoneal dialysis patients (2014) (15)
Increase of IgA in Pharyngeal Washings from Patients with IgA Nephropathy (1983) (15)
Involvement of p300 in TGF-beta/Smad-pathway-mediated alpha2(I) collagen expression in mouse mesangial cells. (2003) (15)
Proposal of remission criteria for IgA nephropathy. (2014) (15)
TWEAK/Fn14 system and crescent formation in IgA nephropathy (2015) (15)
Early induction of the NGFI-B Nur77 family genes in nephritis induced by anti-glomerular basement membrane antibody (1996) (15)
Effect of methylprednisolone on transforming growth factor-beta, insulin-like growth factor-I, and basic fibroblast growth factor gene expression in the kidneys of NZB/W F1 mice. (1993) (15)
[Committee of IgA Nephropathy--the Special Study Group of Progressive Glomerular Disease, the Ministry of Health, Labor and Welfare of Japan]. (2002) (15)
Increased interleukin 6 mRNA expression by peripheral blood T cells from patients with IgA nephropathy. (1993) (14)
FcgammaRIIa-131R allele and FcgammaRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy. (2005) (14)
Abnormal regulation of insulin-like growth factor gene expression in peripheral blood mononuclear cells from patients with IgA nephropathy. (1992) (14)
Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome (2016) (14)
Effects of the PGI2 analog beraprost sodium on glomerular prostanoid synthesis in rats with streptozotocin-induced diabetes. (1996) (14)
Doxorubicin-induced glomerulosclerosis with proteinuria in GFP-GABARAP transgenic mice. (2012) (14)
Levels of circulating IgA immune complexes after gluten-rich diet in patients with IgA nephropathy. (1988) (14)
Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan (2010) (14)
Elevation of serum IgA1 levels in patients with diabetic nephropathy. (1993) (14)
Binding capacity of serum IgA to jacalin in patients with IgA nephropathy using jacalin-coated microplates. (1995) (14)
Effects of antihypertensive drugs on antioxidant enzyme activities and renal function in stroke-prone spontaneously hypertensive rats. (1997) (14)
Peroxisome proliferator‐activated receptor γ gene polymorphism is associated with serum triglyceride levels and body mass index in Japanese type 2 diabetic patients (2004) (14)
Metabolic impact on serum levels of complement component 3 in Japanese patients (2010) (14)
Detection of antigenic substances in patients with IgA nephropathy. (1984) (14)
Risk of Overestimation of Kidney Function Using GFR‐Estimating Equations in Patients with Low Inulin Clearance (2012) (14)
Paracrine effects of transplanted mesothelial cells isolated from temperature-sensitive SV40 large T-antigen gene transgenic rats during peritoneal repair (2013) (14)
Proto-oncogene expression in peripheral blood mononuclear cells in IgA nephropathy. (1991) (14)
The Kinetics of Glomerular Deposition of Nephritogenic IgA (2014) (14)
Relationship between levels of urinary type IV collagen and renal injuries in patients with IgA nephropathy (2004) (14)
Antiproteinuric effect of olmesartan in patients with IgA nephropathy. (2009) (14)
Effect of a specific endothelin receptor A antagonist on glomerulonephritis of ddY mice with IgA nephropathy. (1996) (14)
CARDIAC FUNCTION AND STRUCTURE IN LONGITUDINAL ANALYSIS OF ECHOCARDIOGRAPHY IN PERITONEAL DIALYSIS PATIENTS (2010) (14)
IgA nephropathy associated with HLA-DR4 antigen. (1984) (13)
Increase in proteinuria and/or microhematuria following upper respiratory tract infections in patients with IgA nephropathy. (1984) (13)
Immunofluorescent studies on alpha 2-plasmin inhibitor (alpha 2-PI) in glomeruli from patients with IgA nephropathy. (1985) (13)
Oral Astaxanthin Supplementation Prevents Peritoneal Fibrosis in Rats (2015) (13)
Differential effects of Sendai virus infection on mediator synthesis by mesangial cells from two mouse strains. (2003) (13)
Impact of preoperative ultrasonography findings on the patency rate of vascular access in Japanese hemodialysis patients (2016) (13)
Cross-reactivity of eluted antibodies from renal tissues of patients with henoch-Schönlein purpura nephritis and IgA nephropathy. (1983) (13)
Reevaluation of the mucosa-bone marrow axis in IgA nephropathy with animal models. (2011) (13)
Measurement of soluble thrombomodulin in sera from various clinical stages of diabetic nephropathy (1996) (13)
Disruption of Smad4 Expression in T Cells Leads to IgA Nephropathy-Like Manifestations (2013) (13)
Value of pathological grading in prediction of renal survival in IgA nephropathy (1996) (13)
B-type (brain) natriuretic peptide and pruritus in hemodialysis patients (2014) (13)
DEPOSITION OF IGA‐DOMINANT IMMUNE‐COMPLEXES IN MUSCULAR VESSELS FROM PATIENTS WITH IGA NEPHROPATHY (1981) (13)
Possible mechanism of impaired calcium and vitamin D metabolism in nephrotic rats. (1992) (13)
Pathogenesis of IgA nephropathy. (2007) (13)
Association of Alexithymia with Low Utilization and Perception on a Measure of Social Support in Patients on Peritoneal Dialysis (1997) (13)
Podocyte loss and progression of diabetic nephropathy. (2001) (13)
Complement in patients receiving maintenance hemodialysis: functional screening and quantitative analysis (2010) (12)
N-type calcium channel inhibition with cilnidipine elicits glomerular podocyte protection independent of sympathetic nerve inhibition. (2012) (12)
Detection of viral antigens in patients with IgA nephropathy. (1989) (12)
Effects of Pravastatin on Superoxide and Fibronectin Production of Mesangial Cells Induced by Low-Density Lipoprotein (2002) (12)
Scavenging of reactive oxygen species by astaxanthin inhibits epithelial–mesenchymal transition in high glucose-stimulated mesothelial cells (2017) (12)
Beneficial effect of Astragalus membranaceus on estimated glomerular filtration rate in patients with progressive chronic kidney disease (2012) (12)
Two-color analysis of lymphocyte subpopulations in patients with nephrotic syndrome due to membranous nephropathy. (1992) (12)
Combination Therapy with Telmisartan and Oxacalcitriol Suppresses the Progression of Murine Adriamycin Nephropathy (2015) (12)
Relationship between preoperative radial artery and postoperative arteriovenous fistula blood flow in hemodialysis patients. (2012) (12)
Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy. (2013) (12)
Evaluation of parathyroid hyperplasia by ultrasonographic examination in patients with end‐stage renal failure before and at initiation of dialysis (2003) (12)
Impaired granulocyte function in patients with diabetes mellitus. (1982) (12)
Identification of cellular origin of type I collagen in glomeruli of rats with crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody. (2001) (12)
Randomized trial of an intensified, multifactorial intervention in patients with advanced‐stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT‐Japan) (2020) (12)
IgA nephropathy associated with myasthenia gravis and scleritis. (1981) (12)
Glomerular T cell and monocyte populations in patients with IgA nephropathy. (1989) (12)
Glomerular nonenzymatic glycosylation and lipid peroxide are increased in the early phase of streptozotocin-induced diabetic rats prior to major histopathologic alterations. (1991) (12)
Quantitative evaluation of time-resolved fluorescence microscopy using a new europium label: application to immunofluorescence imaging of nitrotyrosine in kidneys. (2008) (12)
Activated peripheral blood mononuclear cells in IgA nephropathy express platelet-derived growth factor B-chain messenger RNA. (1992) (11)
Experimental evidence of cell dissemination playing a role in pathogenesis of IgA nephropathy in multiple lymphoid organs. (2013) (11)
Amelioration of Angiotensin II–Induced Salt-Sensitive Hypertension by Liver-Type Fatty Acid–Binding Protein in Proximal Tubules (2013) (11)
Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design. (2010) (11)
Improvement of peritoneal calcification after parathyroidectomy in a peritoneal dialysis patient. (2008) (11)
Immunofluorescent demonstration of alpha- fetoprotein and other plasma proteins in yolk sac tumor. (1976) (11)
Detection of IgA1-dominant immune complexes in peripheral blood polymorphonuclear leukocytes by double immunofluorescence in patients with IgA nephropathy. (1984) (11)
Extraglomerular C3 deposition and metabolic impacts in patients with IgA nephropathy. (2013) (11)
Campylobacter fetus subspecies fetus peritonitis in continuous ambulatory peritoneal dialysis. (1993) (11)
A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity (2018) (11)
Predictive factors associated with change rates of LV hypertrophy and renal dysfunction in CKD patients. (2013) (11)
Paradigm shift in activity assessment of IgA nephropathy – optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting (2015) (11)
Type B insulin resistance syndrome with systemic lupus erythematosus. (2010) (10)
Deposition of C4-binding protein and beta 1H globulin in kidneys of patients with IgA nephropathy. (1981) (10)
Application of proteomic analysis to renal disease in the clinic (2009) (10)
Specific binding of circulating IgA antibodies in patients with IgA nephropathy. (1985) (10)
Immune Complex-Mediated Complement Activation in a Patient with IgG4-Related Tubulointerstitial Nephritis (2011) (10)
Determinants of coronary artery calcification in maintenance hemodialysis patients (2015) (10)
Role of Mindin in Diabetic Nephropathy (2011) (10)
Detection of anionic sites and immunoglobulin a deposits in the glomerular capillary walls from patients with Iga nephropathy (1989) (10)
Peroxisome proliferator-activated receptor gamma gene polymorphism is associated with serum triglyceride levels and body mass index in Japanese type 2 diabetic patients. (2004) (10)
Effects of benidipine hydrochloride on antioxidant enzyme activity in stroke‐prone spontaneous hypertensive rats (SHR‐SP) (1997) (10)
Dilazep Hydrochloride, an Antiplatelet Drug, Inhibits Lipopolysaccharide-Induced Mouse Mesangial Cell IL-6 Secretion and Proliferation (2001) (10)
Pentraxin 3 as a new biomarker of peritoneal injury in peritoneal dialysis patients (2013) (10)
Ultrastructural changes in glomerular epithelial cells in acute puromycin aminonucleoside nephrosis: A study by high-resolution scanning electron microscopy (2005) (10)
Long-term outcome of encapsulating peritoneal sclerosis (EPS) patients in a single center (2015) (10)
Beneficial Effects of Combination Therapy with Olmesartan and Azelnidipine in Murine Polycystic Kidneys (2009) (10)
Roles of bone marrow, mucosa and lymphoid tissues in pathogenesis of murine IgA nephropathy. (2007) (10)
Serum levels of interleukin‐2 receptor and disease activity in patients with iga nephropathy (1989) (10)
7-84 parathyroid hormone fragments are proportionally increased with the severity of uremic hyperparathyroidism. (2005) (10)
Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy (2014) (10)
Marked improvement by high-dose chemotherapy and autologous stem cell transplantation in a case of light chain deposition disease. (2011) (10)
Laudatio for Professor Sergio Giovannetti (1999) (10)
Impact of anaemia treatment for left ventricular remodelling prior to initiation of dialysis in chronic kidney disease patients: Efficacy and stability of long acting erythropoietin stimulating agents (2015) (10)
High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia (2017) (10)
Immunopathological predictors of prognosis in IgA nephropathy. (2013) (10)
Clinical effect of danazol in patients with IgA nephropathy. (1987) (10)
Increased Endothelin-1 Mrna Expression in Peripheral Blood Monocytes of Dialysis Patients (1997) (9)
Cytopathic effects of antigens in patients with IgA nephropathy. (1986) (9)
Correlations among Expression of Glomerular Intercellular Adhesion Molecule 1 (ICAM-1), Levels of Serum Soluble ICAM-1, and Renal Histopathology in Patients with IgA Nephropathy (1999) (9)
Retroviral envelope glycoprotein (gp 70) is not a prerequisite for pathogenesis of primary immunoglobulin A nephropathy in ddY mice. (1992) (9)
Sorting Nexin 9 facilitates podocin endocytosis in the injured podocyte (2017) (9)
[A case report of chronic tubulo-interstitial nephritis]. (1992) (9)
Exercise-Induced Acute Kidney Injury in a Police Officer with Hereditary Renal Hypouricemia (2019) (9)
Increase of Peripheral Blood B Cells with Fc Receptor for IgA in Patients with IgA Nephropathy (1983) (9)
Tensin Is Expressed in Glomerular Mesangial Cells and Is Related to Their Attachment to Surrounding Extracellular Matrix (2004) (9)
IMMUNOPATHOLOGICAL SIMILARITIES BETWEEN IgA NEPHROPATHY and HENOCH‐SCHOENLEIN PURPURA (HSP) NEPHRITIS (1983) (9)
Clinical Features of Hereditary and Mast Cell-mediated Angioedema Focusing on the Differential Diagnosis in Japanese Patients (2017) (9)
A case of Behçet's disease associated with membranous nephropathy. (1984) (9)
Clinical effect of the anti-platelet drug, dilazep dihydrochloride, in patients at the microalbuminuric stage of diabetic nephropathy--a multi-center study. (1995) (9)
An analysis of functional activity via the three complement pathways during hemodialysis sessions: a new insight into the association between the lectin pathway and C5 activation (2012) (9)
Campylobacter Bacteremia in Hemodialysis Patients by Eating Raw Meat – The Importance of Sanitary Education (2012) (9)
DOUBLE IMMUNOFLUORESCENCE STUDIES OF IMMUNOGLOBULINS, COMPLEMENT COMPONENTS AND THEIR CONTROL PROTEINS IN PATIENTS WITH IgA NEPHROPATHY (1982) (9)
Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia--changes in serum potassium levels with or without a RAAS inhibitor. (2007) (9)
[Factors associated with cardiovascular death and events in patients with end stage renal disease]. (2013) (9)
Multicentric Castleman's disease associated with renal amyloidosis and pure red cell aplasia (1998) (9)
An Intron 4 Gene Polymorphism in Endothelial Cell Nitric Oxide Synthase Might Modulate Lipid Metabolism in Nondiabetic Patients on Hemodialysis (2001) (8)
Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats. (1995) (8)
Effects of l-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis (2020) (8)
Computer Imaging Analysis of Glomerular Extracellular Components in Patients with IgA Nephropathy (1989) (8)
Improvement of rapidly progressive lupus nephritis associated MPO-ANCA with tacrolimus (2010) (8)
Glucocorticoid ameliorates altered gene expression of extracellular matrix components in kidneys of New Zealand black/white F1 mice. (1992) (8)
Exacerbating factors in patients with IgA nephropathy. (1987) (8)
Expression and physical association of Fc a receptor and Fc receptor c chain in human mesangial cells (1999) (8)
One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney disease. (2011) (8)
Effects of dietary Ca2+ on erythrocyte Na(+)-transport systems in spontaneously hypertensive rats. (1991) (8)
Detection of polymorphonuclear cells, superoxide dismutase and poly C9 in glomeruli of patients with IgA nephropathy. (1991) (8)
Suffocation due to Acute Airway Edema in a Patient with Hereditary Angioedema Highlighted the Need for Urgent Improvements in Treatment Availability in Japan (2018) (8)
Rac1 in podocytes promotes glomerular repair and limits the formation of sclerosis (2018) (8)
Novel coronavirus disease in patients with end‐stage kidney disease (2020) (8)
Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1–3) patients (2016) (8)
Perforin mRNA expression in the inflamed tissues of NZB/W F1 lupus mice decreases with methylprednisolone treatment. (1991) (8)
Effects of calcium antagonists in hypertensive patients with renal dysfunction: A prospective, randomized, parallel trial comparing benidipine and nifedipine (2004) (8)
Acquired Loss of Erythrocyte Complement Receptor Type 1 in Patients with Diabetic Nephropathy Undergoing Hemodialysis (2006) (8)
Spontaneous animal model, ddY mouse, for studying the pathogenesis and treatment in patients with immunoglobulin A nephropathy (2010) (8)
Identification of quantitative trait loci for diabetic nephropathy in KK-Ay/Ta mice. (2012) (8)
Significance of broad distribution of electron-dense deposits in patients with IgA nephropathy (2012) (7)
Glomerular alterations in children with biliary atresia. (1992) (7)
Antigenic heterogeneity in patients with IgA nephropathy. (1987) (7)
Detection of 'activated platelets' in the urinary sediments using a scanning electron microscope in patients with IgA nephropathy. (1990) (7)
Detection of antioxidant enzyme activities in renal tissues of early stage IgA nephropathy in ddY mice (1996) (7)
Osteodystrophy in Indonesian haemodialysis patients (2003) (7)
Immunoglobulin A nephropathy and chronic kidney disease (2010) (7)
Relationship among Left Ventricular Hypertrophy, Cardiovascular Events, and Preferred Blood Pressure Measurement Timing in Hemodialysis Patients (2020) (7)
EVALUATION OF THE STAINING CONDITIONS OF IMMUNOFLUORESCENCE IN PRIMARY GLOMERULONEPHRITIS (1981) (7)
Association of serum uric acid, morning home blood pressure and cardiovascular risk factors in a population with previous prehypertension: a cross-sectional study (2020) (7)
Evidence of immunopathological traces in mucormycosis: an autopsy case (2010) (7)
Efficacy of adsorbent in delaying dialysis initiation among chronic kidney disease patients (2011) (7)
Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy (2016) (7)
Renal Hemodynamics Attenuating effect of angiotensin-( 1 – 7 ) on angiotensin II-mediated NAD ( P ) H oxidase activation in type 2 diabetic nephropathy of KK-Ay / Ta mice (2011) (7)
Detection of immunoglobulins and/or complement in kidney tissues from non-obese diabetic (NOD) mice. (1987) (7)
In situ hybridization of type I collagen mRNA in puromycin aminonucleoside-induced glomerulosclerosis. (1995) (7)
Renoprotective effects of the L-/T-type calcium channel blocker benidipine in patients with hypertension. (2013) (7)
Association of IgA nephropathy and myasthenia gravis. (1989) (7)
Subpopulations of Tα cells in patients with IgA nephropathy: Correlation between Tα 4 cells and in vitro IgA production (1989) (7)
Diminished capacity of opsonization and immune complex solubilization, and detection of anti-C1q antibodies in sera from patients with hereditary angioedema. (2017) (7)
Effects of Cardiac Function with Postoperative Arteriovenous Fistula Blood Flow in Patients with Hemodialysis (2017) (7)
Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis. (1998) (7)
A Paradigm Shift for the Concept of Diabetic Nephropathy (2014) (6)
Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA. (2016) (6)
Pharmacokinetics of Calcitriol and Maxacalcitol Administered into Peritoneal Dialysate Bags in Peritoneal Dialysis Patients (2005) (6)
Immunogenetical study in patients with chronic glomerulonephritis. (1983) (6)
Efficacy of ACE inhibitor (captopril) on glomerular antioxidant enzyme activity and hypertension in diabetic hypertensive rats. (2001) (6)
Effect of Predialysis Recombinant Human Erythropoietin on Early Survival After Hemodialysis Initiation in Patients With Chronic Kidney Disease: Co‐JET Study (2016) (6)
Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy (2014) (6)
Double immunofluorescence studies on IgA-associated immune-complexes in glomerular deposits in patients with IgA nephropathy. (1980) (6)
Laparoscopic Manipulation for Outflow Failure of Peritoneal Dialysis Catheter (1999) (6)
[Serum superoxide dismutase (SOD) activity in patients with renal disease by a spintrap method using electron spin resonance (ESR)]. (1993) (6)
IgA nephropathy with "Full House" immunofluorescence. (1983) (6)
Predictors of prognosis in IgA nephropathy (2012) (6)
The Future: A Japanese Perspective (1987) (6)
Increase of in vivo and in vitro production of polyclonal IgA in patients and their family members with IgA nephropathy. (1987) (6)
Severity of Alexithymia is Related to Psychosocial Factors in Patients with Peritoneal Dialysis (1995) (6)
Effects of dialysis on the pharmacokinetics of salazosulfapyridine (2013) (6)
A case of reflex anuria and uremia related to a unilateral ureteral stone. (1996) (6)
Using protein/creatinine ratios in random urine (2005) (6)
A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine (2004) (6)
Correlation between tubulointerstitial changes and prognosis in patients with primary membranous nephropathy. (1994) (6)
Distribution of dimethylarginine-dimethylaminohydrolase-II (DDAH2) gene polymorphism in hemodialysis patients. (2013) (6)
High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia (2017) (6)
Increased expression of proliferating cell nuclear antigen mRNA in peripheral blood mononuclear cells from patients with IgA nephropathy. (1991) (6)
A new screening method for proteinuria using Erythrosin B and an automated analyzer--rapid, sensitive and inexpensive determination. (2012) (6)
[Comparison of prediction equations of glomerular filtration rate in Japanese adults]. (2006) (6)
Correlation between reduction of polymorphonuclear leucocytes in glomeruli injected with a newly developed monoclonal antineutrophil antibody and proteinuria in Masugi nephritis. (1992) (6)
Double immunofluorescence studies of IgA and poly C9 (MAC) in glomeruli from patients with IgA nephropathy. (1987) (6)
Pathogenesis and treatment of type 2 diabetic nephropathy: lessons from the spontaneous KK/Ta mouse model. (2005) (6)
Gender‐ and disease‐specific urinary thioredoxin in chronic kidney disease patients with or without type 2 diabetic nephropathy (2015) (6)
Altered mouse cholinephosphotransferase gene expression in kidneys of type 2 diabetic KK/TA mouse. (2004) (6)
[Effect of parathyroid hormone-related protein on Na(+)-dependent phosphate transport in renal brush border membrane vesicles in rats]. (1991) (6)
Establishment of a peritoneal mesothelial cell line from a transgenic rat harbouring the temperature-sensitive simian virus 40 large T-antigen gene. (2010) (6)
Correlation of renal histopathology duration of diabetes, and control of blood glucose in patients with type II diabetes. (1987) (6)
Effect of the Direct Renin Inhibitor Aliskiren on Urinary Albumin Excretion in Spontaneous Type 2 Diabetic KK-A y Mouse (2013) (6)
Cold reacting anti-nuclear factor (ANF) in families of patients with IgA nephropathy. (1984) (6)
A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin. (2009) (6)
Effect of Valsartan, an Angiotensin II AT1 Receptor Blocker, on the Glomerular Fibrosis of IgA Nephropathy in ddY Mice (2000) (6)
Genetic susceptibility to type 2 diabetic nephropathy in human and animal models (2005) (6)
Effect of monoclonal antibody CD4 on expression of intercellular adhesion molecule 1 in renal tissues of ddY mice: a spontaneous animal model of IgA nephropathy. (1994) (6)
Detection of glycosylated protein in renal tissues and dermal vascular vessels in the microalbuminuric stage of diabetic nephropathy using the nitro blue tetrazolium reaction. (1994) (5)
Detection of malondialdehyde levels and superoxide dismutase activities in renal tissues of nonobese diabetic mice. (1990) (5)
Severe erosive lesions in the digestive tract of patients with Henoch-Schönlein Purpura (HSP) and its impact on prognosis - presentation of two cases and statistical review of adult-onset Japanese HSP. (2011) (5)
Effect of Calcium Channel Blockers, Nifedipine and Benidipine, on Death of Cultured Mouse Mesangi al Cells (2000) (5)
Effect of unilateral nephrectomy on gene expression of metalloproteinases and their inhibitors. (1997) (5)
Urinary type-IV collagen. (2001) (5)
Protein Localization and mRNA Expression of Epimorphin in Mouse and Human Kidneys (2001) (5)
Rapid immunofluorescence by microwave incubation. (1988) (5)
Suppressive Activity of Pemirolast Potassium, an Antiallergic Drug, on Glomerulonephritis (2008) (5)
Analysis of innate immune responses in a model of IgA nephropathy induced by Sendai virus. (2007) (5)
Effects of antiplatelet drug dilazep dihydrochloride on anionic sites and extracellular matrix (ecm) components in glomerular basement membrane of stz‐induced diabetic rats (1995) (5)
Vitamin D metabolism in nephrotic rats. (1991) (5)
IgA Nephropathy Today (2007) (5)
[Comparative studies of clinicopathological findings in patients with adult and juvenile onset of IgA nephropathy]. (1989) (5)
Analysis of Predictive Factors for Deterioration of Renal Function in Chronic Kidney Disease Patients (2016) (5)
A case of Fabry's disease. (1983) (5)
Measurement of mouse urinary type IV collagen using time-resolved fluoroimmunoassay. (2003) (5)
Relationship between renal anemia and prognostic stages of IgA nephropathy (2005) (5)
Pathogenetic and therapeutic approaches to IgA nephropathy using a spontaneous animal model, the ddY mouse (2011) (5)
Modulation of endothelin family gene expression in renal hypertrophy. (1996) (5)
Effect of Dilazep Hydrochloride, an Antiplatelet Agent, on the Proliferation of Cultured Mouse Glomerular Mesangial Cells (2000) (5)
Prevalence of IgAl deposits in Henoch-Schoenlein purpura (HSP) nephritis. (1982) (5)
Aberration of B and T cell subsets in patients with IgA nephropathy and membranous nephropathy. (1984) (5)
Effect of immunoglobulin depositions of glomerular sialic acids in patients with IgA nephropathy. (1986) (5)
Effect of parathyroid-hormone-related protein on sodium-dependent phosphate transport in renal brush border membrane vesicles in rats. Comparison with parathyroid hormone. (1993) (5)
A case of neuroleptic malignant syndrome with acute renal failure after the discontinuation of sulpiride and maprotiline. (1991) (5)
The effects of soursop supplementation on blood pressure, serum uric acid, and kidney function in a prehypertensive population in accordance with the 2017 ACC/AHA guideline (2019) (5)
Contribution of high concentrations of PTH(1-34) to muscle weakness in uremia by suppression of guanidinoacetic acid synthesis. (1991) (5)
Effects of the antihypertensive drug efonidipine hydrochloride on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes. (1998) (5)
Is the new GFR equation using inulin clearance a more accurate method for Asian patients? (2015) (5)
Usefulness of HPLC Assay for Early Detection of Microalbuminuria in Chronic Kidney Disease (2013) (5)
Mechanisms of Progression (1999) (5)
Baseline characteristics and anemia treatment for new hemodialysis patients (2008) (5)
Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis. (2002) (5)
Re-expression of Sall1 in podocytes protects against adriamycin-induced nephrosis (2017) (5)
Glomerular Nonmuscle-Type Myosin Heavy-Chain Isoform Gene Expression in Glomerulosclerosis (1998) (5)
Immunofluorescent studies on acute phase reactants in patients with various types of chronic glomerulonephritis. (1981) (4)
Immunotherapy in IgA nephropathy (1997) (4)
Focal segmental glomerulosclerosis associated with a pheochromocytoma. (1984) (4)
Serum Insulin-Like Growth Factor 1 Level and Nutritional Assessment in Nondialytic Patients with Chronic Renal Failure (2002) (4)
Relationship between acceleration plethysmography and aortic calcification index in chronic kidney disease patients (2012) (4)
Detection of activated platelets in urinary sediments by immunofluorescence using monoclonal antibody to human platelet GMP‐140 in patients with IgA nephropathy (1993) (4)
Serum Levels of Soluble Fas and Disease Activity in Patients with IgA Nephropathy (1999) (4)
Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis. (1996) (4)
[Clinical symptoms and laboratory findings in patients with IgA nephropathy (author's transl)]. (1981) (4)
Lessons from the Spontaneous Mouse Models for Treatment of Type 2 Diabetic Nephropathy and IgA Nephropathy (2009) (4)
Detection of glycosylated protein in glomeruli of STZ‐induced diabetic rats using the nitroblue tetrazolium (NBT) reaction (1994) (4)
HEPATITIS C VIRUS INFECTION IN HEMODIALYSIS PATIENTS: COMPARISON OF THE SURABAYA DIALYSIS CENTER AND JUNTENDO UNIVERSITY HOSPITAL DIALYSIS CENTRE (2010) (4)
Successful use of continuous ambulatory peritoneal dialysis (CAPD) in the treatment of patients with renal and cardiac failure. (1986) (4)
Adaptation of low-phosphate diet in renal brush borders of spontaneously hypertensive rats. (1991) (4)
Discrepancy of Serum IgA Levels Determined by Single Radial Immunodiffusion and Laser Nephelometry in Patients with IgA Nephropathy (1985) (4)
Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells. (2014) (4)
Successfully maintained hemodialysis for the treatment of chronic renal failure in a patient with Hallopeau–Siemens type recessive dystrophic epidermolysis bullosa (2012) (4)
Widening of capillary neck and alteration of extracellular matrix ultrastructure in diabetic rat glomerulus as revealed by computer morphometry and improved tissue processing (2005) (4)
Early Diagnosis of CAPD Peritonitis Using a New Test Kit for Detection of Matrix Metalloproteinase (MMP)-9 (2004) (4)
Leukocytapheresis (LCAP) for the treatment of rheumatoid arthritis on a maintenance hemodialysis patient. (2007) (4)
Specificity of IgA antibody in IgA nephropathy. (1981) (4)
Modified open renal biopsy. (1980) (4)
Definition and Synonyms (1999) (4)
Increased remission of early stage membranous nephropathy on long-term treatment with corticosteroid. (1992) (4)
EVALUATION OF THE STAINING FINDINGS OF IMMUNOFLUORESCENCE IN UNFIXED OR FIXED RENAL BIOPSY SPECIMENS FROM PATIENTS WITH IGA NEPHROPATHY and MEMBRANOUS NEPHROPATHY (1985) (4)
IgA deposits might not influence the production of extracellular matrix in glomeruli of ddY mice, a spontaneous animal model for IgA nephropathy. (1994) (4)
[Effective usage of nutrition assessment proteins in patients with diabetic nephropathy]. (2004) (4)
Computer imaging analysis of the correlation between intensities of glomerular immune-deposits and histopathology in patients with IgA nephropathy. (1991) (4)
Preliminary study on specificity of IgA released from lymphocytes by EB virus transformation in patients with IgA nephropathy. (1990) (4)
Effects of enalapril treatment on gene expression of smooth muscle myosin heavy chain isoforms in glomeruli of diabetic rats. (1995) (3)
Correlation between the pharyngeal secretion of IgA, secretory-IgA and free secretory component and the upper respiratory tract infections in patients with IgA nephropathy. (1987) (3)
Influence of the period between onset of IgA nephropathy and medical intervention on renal prognosis (2011) (3)
Significant correlation between the immunofluorescence of alpha 2-plasmin inhibitor in glomeruli and the effects of urokinase therapy in patients with IgA nephropathy. (1986) (3)
Neurofilament heavy polypeptide protects against reduction in synaptopodin expression and prevents podocyte detachment (2018) (3)
Pathogenesis and Treatment of IgA Nephropathy (2000) (3)
Laparoscope Is a Useful Tool for Reducing and Drawing off a Peritoneal Dialysis Catheter in Peritoneal Dialysis Patients (2016) (3)
A case of IgA nephropathy associated with marked hematuria after upper respiratory tract infections. (1982) (3)
Experimental Models of Type-2 Diabetic Nephropathy (2012) (3)
Effect of probucol on mRNA expression of glomerular antioxidant enzymes in rat with subtotal nephrectomy. (1996) (3)
Far-infrared therapy for secondary vascular access patency of hemodialysis patients (2019) (3)
Perforin gene expression in T lymphocytes correlates with disease activity in immunoglobulin A nephropathy. (1992) (3)
A case of lupus nephritis showing good clinical course and apoptosis in glomerular cells detected by the nick end labeling method. (1997) (3)
Immunofluorescent analysis of extracellular matrix (ECM) components in glomeruli of the hepatic glomerulosclerosis. (1993) (3)
Chronological Change of the Serum IgA/C3 Ratio Indicates the Efficacy ofTonsillectomy for IgA Nephropathy (2016) (3)
Determination of Sensitivity and Specificity of the Micral-Test II Strip for Detection of Microalbuminuria in Diabetic and Nondiabetic Patients (1999) (3)
[Hypersensitivity angiitis, Henoch-Schönlein purpura]. (1994) (3)
Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study (2022) (3)
Clinical effect of dipyridamole in patients with IgA nephropathy. (1986) (3)
Two adult cases of IgM-associated mesangial proliferative glomerulonephritis. (1994) (3)
Effect of benidipine on decreasing glomerular expansion in the experimental nephrotic syndrome. (1995) (3)
[A study about normal values of urinary type IV collagen concentration--aim at constructing a diagnostic guideline for diabetic nephropathy]. (2002) (3)
Abnormal Glucose Tolerance in Patients with Chronic Glomerulonephritis Without Renal Failure (1983) (3)
Defibrination of intraglomerular fibrin deposits by urokinase in patients with IgA nephropathy. (1984) (3)
How to treat patients with chronic kidney disease: With special focus on IgA nephropathy (2018) (3)
A case of granulomatous renal sarcoidosis with a dramatic response to corticosteroid and urokinase therapy. (1983) (3)
Detection of platelets in urinary sediments from patients with “Advanced” stages of immunoglobulin a nephropathy (1988) (3)
Subpopulations of T alpha cells in patients with IgA nephropathy: correlation between T alpha 4 cells and in vitro IgA production. (1989) (3)
Diagnosis and therapy of diabetic nephropathy (1997) (3)
[Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy]. (2004) (3)
[Drug-induced kidney injury]. (2012) (3)
Effect of a specific endothelin receptor A antagonist on murine lupus nephritis and IgA nephropathy. (1996) (3)
Podocyte loss and albuminuria of KK-Ay mouse: A spontaneous animal model for human type 2 diabetic nephropathy (2012) (3)
[Immunohistochemical analysis of protein gene product 9.5, a new marker for parietal epithelial cells of Bowman's capsules, in anti-glomerular basement membrane(GBM) antibody induced glomerulonephritis of WKY rats]. (2001) (3)
[A case of gastric antral vascular ectasia (GAVE) with chronic renal failure]. (2001) (2)
A Case of Arteriovenous Fistula after Renal Biopsy in an IgA Nephropathy Patient with Macroscopic Hematuria (2013) (2)
Can urine polypeptide profiles be used to diagnose IgA nephropathy? (2005) (2)
MP226CLINICAL ADVANTAGE OF CONCOMITANT USE OF MIZORIBINE AND PREDNISOLONE ON PRIMARY MEMBRANOUS NEPHROPATHY IN THE ELDERLY (2017) (2)
Effect of Dilazep Hydrochlorideon the Im munohistopathology of IgA Nephropathy in ddY Mice (2000) (2)
[Morphometric analysis of normal glomerular epithelial cells in rat and human]. (1999) (2)
Relationship between the serum IgA/C3 ratio and the progression of IgA nephropathy. (2004) (2)
Thyroid Storm Masked by Hemodialysis and Glucocorticoid Therapy in a Patient with Rheumatoid Arthritis (2012) (2)
Influence of Estrogen on the Progression of Kidney Injury in Murine IgA Nephropathy (2017) (2)
Contents, Vol. 4, 1993 (1993) (2)
Effect of N-acetylcysteine on Malondyaldehyde Content After Iron Treatment in Chronic Kidney Disease Stage 5D Patients (2012) (2)
Evaluation of switching treatment from high dose of darbepoetin to lower dose of roxadustat in Japanese hemodialysis patients (2021) (2)
An adult case of Fanconi's syndrome associated with membranous nephropathy. (1986) (2)
Effect of low-protein diet on glomerular changes in ddY mice: a spontaneous animal model of IgA nephropathy. (1996) (2)
Correlation between glomerular injuries and the existence of cytokines in glomeruli of patients with IgA nephropathy. (1993) (2)
Immunofluorescent studies on IgA nephropathy: type IV collagen and glomerular basement membrane component detected by Goodpasture's syndrome serum and laminin. (1988) (2)
Glomerular IgA deposition through Th2-dominant mucosal immune responses (2005) (2)
Effect of Acarbose on Blood Glucose and Proteinuria in Patients with Diabetic Nephropathy (2000) (2)
Comparison Between the Fixation of Peritoneal Dialysis Catheters to the Peritoneal Wall and the Conventional Placement Technique: Clinical Experience and Follow‐Up of a New Implant Technique for Peritoneal Dialysis Catheters (2014) (2)
Clinical effect of newly developed oral carbonaceous adsorbent (AST-120) in patients with advanced stages of chronic glomerulonephritis. (1987) (2)
Pancreatic lipase activity in overnight effluent predicts high transport status in peritoneal dialysis patients. (2016) (2)
Dimethylarginine Dimethylaminohydrolase 2 Gene Polymorphism and Its Association with Asymmetrical Dimethyl Arginine in Hemodialyzed Patients (2013) (2)
A case of thin basement membrane syndrome associated with idiopathic membranous nephropathy. (1994) (2)
Detection of polymeric IgA in sera from patients with IgA nephropathy determined by thin-layer gel filtration. (1984) (2)
Multicenter laparoscopic evaluation of the peritoneum in peritoneal dialysis patients (2020) (2)
[Concept and epidemiology of diabetic nephropathy]. (2005) (2)
Correlation of paramesangial deposits and glomerular sclerosis and/or hyalinosis in patients with IgA nephropathy. (1986) (2)
Experimental Model of IgA Nephropathy (2009) (2)
Effects of low-protein diet on mRNA for ECM components, MMPs and TIMPs in glomeruli of focal glomerular sclerosis. (1994) (2)
Recent Understanding of Peritoneal Pathology in Peritoneal Dialysis Patients in Japan (2021) (2)
Effect of NK-104 on proliferation of cells (2001) (2)
Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy: response to comment (2014) (2)
[Pathogenesis of IgA nephropathy: current understanding of mucosa-bone marrow axis in IgA nephropathy]. (2008) (2)
Evidence of latent pathogenesis of Propionibacterium acnes infection in a patient with renal sarcoidosis (2010) (2)
STUDIES ON GLOMERULAR IMMUNE SOLUBILIZATION BY COMPLEMENT IN PATIENTS WITH IgA NEPHROPATHY (1987) (2)
Contents Vol. 59, 1999 (1999) (2)
Laparoscopic Findings in Peritoneal Dialysis Patients (2005) (2)
Transperitoneal Calcium Balance in Anuric Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients (2013) (2)
Type-2 Diabetic Nephropathy in Japan: From Bench to Bedside (2001) (2)
Progressive Renal Dysfunction due to IgG4-Related Kidney Disease Refractory to Steroid Therapy: A Case Report (2019) (2)
A case of nephrotic syndrome associated with hepatic glomerulosclerosis and diabetic nephropathy. (1993) (2)
Effects of a "single shot" of urokinase on fibrinolytic activities in patients with IgA nephropathy. (1984) (2)
Effects of endothelin 1 on phosphate transport in brush border membrane vesicles. (1997) (2)
Handgrip strength , but not other nutrition parameters , predicts circulatory congestion in peritoneal dialysis patients (2010) (2)
[Vasculitic syndrome]. (1996) (2)
Siblings with IgA nephropathy and diffuse proliferative glomerulonephritis (PGN) associated with identical HL-A antigens. (1986) (2)
Clinical nephrology - IgA nephropathy, lupus nephritis, vasculitis (2013) (2)
A case of Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD) (2001) (1)
Clinical and Histological Characteristics in Patients with Non-IgA Mesangioproliferative Glomerulonephritis (2015) (1)
ACTI ON OF N- ACETYLCYSTEI NE ON ASYMMETRI C DIMETHYLARGININE AND ALBUMINURIA IN STAGE 1-4 NONDIABETIC CHRONIC KIDNEY DISEASE PATIENTS (2010) (1)
IMMUNOFLUORESCENCE STAINING IN UNFIXED OR FIXED RENAL BIOPSY SPECIMENS FROM PATIENTS WITH DIABETIC NEPHROPATHY (1985) (1)
Usefulness of Change in Estimated Glomerular Filtration Rate as a Predicting Factor of Progression of Chronic Kidney Disease (2012) (1)
A case of mesangial IgM nephropathy with decreased renal function. (1984) (1)
Altered mRNA expression of basement membrane components in focal glomerular sclerosis. (1991) (1)
A6256 ASSOCIATED GENDER DIFFERENCES BETWEEN SERUM URIC ACID, MORNING HOME BLOOD PRESSURE MONITORING AND CARDIOVASCULAR RISK FACTORS PREVALENCE AFTER 10 YEARS BASED ON REGIONAL COHORT STUDY IN THE JAVANESE PREHYPERTENSION POPULATION IN INDONESIA (2018) (1)
Siblings with IgA nephropathy and diffuse proliferative glomerulonephritis, without mesangial IgA deposits (PGN), associated with identical HL-A antigens. (1984) (1)
Hepatic glomerulosclerosis with IgA deposition. Report of three cases. (1983) (1)
Newly Identified Molecules Related to Podocyte Injury Induced by Adriamycin (2015) (1)
EFFECT OF IMMUNOGLOBULIN DEPOSITION ON THE AMOUNT OF GLOMERULAR SIALIC ACIDS IN PATIENTS WITH MEMBRANOUS NEPHROPATHY (1986) (1)
An overview of dialysis treatment in Juntendo Koto Geriatric Medical Center (KGMC) for the first five years of operation. (2008) (1)
[A case of Alport syndrome diagnosed by immunofluorescence using a newly defined monoclonal antibody]. (1990) (1)
Mapping of susceptibility loci for lupus nephritis (1998) (1)
Early diagnosis of CAPD peritonitis by a test kit for detecting leukocyturia(Leukostix). (1991) (1)
A case of peritoneal dialysis (PD) patient complicated with diaphragmatic hernia, inguinal hernia and diaphragmatic communication (2006) (1)
[Clinical guideline review: IgA nephropathies]. (2002) (1)
Pleiotropic effect of pitavastatin on type 2 diabetic nephropathy in KK-A^y/Ta mice (2008) (1)
Overview of medical education for graduates of Juntendo University (2006) (1)
[Regulation of actin cytoskeleton in renal podocytes]. (2008) (1)
New Insights into the Pathogenesis and Treatment of Patients with Immunoglobulin A Nephropathy (2012) (1)
Effects of acute and chronic parathyroidectomy on phosphate transport in brush border membrane vesicles (1989) (1)
Reactive Oxygen Species, Nitric Oxide and the Kidney (2010) (1)
Immunotactoid Glomerulopathy with Nontuberculous Mycobacterial Infection: A Novel Association (2021) (1)
Successful maintenance hemodialysis with permanent vascular catheter in a patient with recessive dystrophic epidermolysis bullosa hereditaria (2009) (1)
Primary and secondary glomerulonephritis I (2012) (1)
Effect of beraprost sodium, a PGI2 analogue, on proliferation of cultured rat glomerular mesangial cells. (1996) (1)
b -trace Protein, a New Marker of GFR, May Predict the Early Prognostic Stages of Patients With Type 2 Diabetic Nephropathy (2004) (1)
Prophylactic treatment of hereditary angioneurotic edema with anabolic steroids. (1980) (1)
Activity of cleaving enzymes for bradykinin in sera from patients with hereditary angioedema (2016) (1)
Classification of type-2 diabetic nephropathy in Japan. (2001) (1)
[Tubulointerstitial nephropathy in mitochondrial cytopathy]. (2002) (1)
Importance of AST-120 (Kremezin®) Adherence in a Chronic Kidney Disease Patient with Diabetes (2018) (1)
Comparative studies among morphological changes of urinary sediments and histopathological injuries in patients with IgA nephropathy. (1987) (1)
Prednisolone‐loaded liposome decreases the accumulation of glomerular extracellular matrix and glomerular injury of immunoglobulin A nephropathy in ddY mice (2002) (1)
Acceleration of crescent formation by L1 retrotransposon in mouse BSA-induced nephritis. (2013) (1)
Overestimation of the risk of progression to end-stage renal disease in the poor prognosis’ group according to the 2002 Japanese histological classification for immunoglobulin A nephropathy (2013) (1)
Association of the Cardioankle Vascular Index and Ankle-Brachial Index with Carotid Artery Intima Media Thickness in Hemodialysis Patients (2013) (1)
[Symptoms in patients with tubulo-interstitial nephritis]. (1995) (1)
Immunohistochemical studies of glomerular extracellular components in repeated renal biopsies of patients with IgA nephropathy. (1991) (1)
MPGN Type 3 Associated with Pemphigus Herpetiformis Mimicking PGNMID and Dermatitis Herpetiformis (2019) (1)
Serum Cystatin C Levels in Hypertensive Type 2 Diabetic Nephropathy Patients after Treatment with Angiotensin Converting Enzyme (ACE) Inhibitor Temocapril (2002) (1)
Double immunofluorescence studies of glomerular sialic acids in patients with diabetic nephropathy. (1987) (1)
Clinical Significance of Renal Interstitial Fibrosis in Patients with Lupus Nephritis (2015) (1)
Comprar Pathogenesis And Treatment In Iga Nephropathy. An International Comparison | Yasuhiko Tomino | 9784431555872 | Springer (2016) (1)
Basic research in progressive glomerulopathies: the role of fibrosing factors in IgA nephropathy and diabetic nephropathy. (2005) (1)
Effects of the antihypertensive drug nifedipine on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes. (1999) (1)
Cerivastatin inhibits fetal calf serunvinduced DNA synthesis in cultured rat mesangial cells (2002) (1)
Alteration of IgA1 glycosylation by down-regulation of core 1 β1,3-galactosyltransferase and its molecular chaperone Cosmc by Th2 cytokine (2006) (1)
[Acute-chronic pyelonephritis]. (1999) (1)
Rac1 in podocytes promotes glomerular repair and limits the formation of sclerosis (2018) (0)
Field measurement on thermal comfort of patients and medical staff in a dialysis room (2014) (0)
4. Physiopathology and Treatment of Chronic Renal Failure. (2010) (0)
A case of encapsulating peritoneal sclerosis developing 5 years after the cessation of peritoneal dialysis associated with calcification in the terminal ileum (2012) (0)
FP562SUPPRESSIVE EFFECT OF ASTAXANTIN ON EPITHERIAL MESENCHYMAL TRANSITION IN MESOTHELIAL CELLS ISOLATED FROM TEMPARATURE SENSITIVE SV40 LARGE T ANTIGEN GENE TRANSGENIC RATS (2015) (0)
Immunological kidney diseases (WS-098) Chairpersons: Yasuhiko Tomino, Jan Novak (2010) (0)
Association of gene polymorphism of polymeric immunoglobulin receptor and IgA nephropathy. (2001) (0)
A Case of Fabry Disease, in Which Renal Symptoms Served as a Diagnostic Prompt (2014) (0)
FP227CLINICAL SIGNIFICANCE OF MIZORIBINE IN ELDERLY PATIENTS WITH PRIMARY MEMBRANOUS NEPHROPATHY (2019) (0)
Contents Vol. 83, 1999 (1999) (0)
Contributions to Nephrology; IgA nephropathy From molecules to men (1999) (0)
THE PATHOGENETIC ROLE OF TONSILLAR B CELL PRODUCING APRIL IN IGA NEPHROPATHY (2014) (0)
Papillary necrosis and the antinuclear factor. (1980) (0)
Role of mucosal immunity dependent on GATA‐3 in glomerular IgA deposition (2005) (0)
[Survey of hemodialysis inpatients in long-term care facilities]. (2005) (0)
[Problems in treatment of kidney failure (discussion)]. (1998) (0)
Correlation between the hyperproduction of glomerular extracellular proteins and the progression of glomerular lesion in IgA nephropathy (1989) (0)
Pitavastatin Compared with Differential Intervention Trial by Standard Therapy on Cardiovascular Events in Patients with Dyslipidemia on Chronic Hemodialysis (DIALYSIS): A Randomized Controlled Trial. (2023) (0)
Significant Fluctuations in Total Complement Hemolytic Activity as a Nutritional Parameter After Transition from Hemodialysis to Online Hemodiafiltration (2019) (0)
[Schoenlein-Henoch purpura and hypersensitivity angitis]. (1985) (0)
Subject Index, Vol. 47, 1987 (1987) (0)
A case of immunoglobulin A nephropathy with a long history (32 years) in the relatively poor prognosis group (2003) (0)
Tubulointerstitial Nephritis and Uveitis Syndrome Associated with Renal Tryptaseand Chymase-positive Mast Cell Infiltration (2007) (0)
A overview of Hemodialysis Therapy in our Insititution Between 1980 and 2008 (2009) (0)
[Pathophysiology of the kidney and urinalysis]. (1998) (0)
Monitoring of serum hepatitis C virus RNA level during steroid therapy for hepatitis C virus-positive antineutrophil cytoplasmic antibody-related glomerulonephritis: report of two cases (2001) (0)
Cathepsin D in podocytes plays an important role in the pathogenesis of proteinuria and 1 chronic kidney disease 2 3 (2016) (0)
A case of mixed connective tissue disease (MCTD) associated with pulmonary hypertension (1986) (0)
Clinicopathological Classification of Primary Glomerulonephritis (1979) (0)
Subject Index, Vol. 17, 1994 (1994) (0)
Subject Index Vol. 89, 2001 (2001) (0)
[Molecular mechanism for the onset and progression of IgA nephropathy]. (2001) (0)
Effects of dietary calcium on erythrocyte sodium ion transport systems in spontaneously hypertensive rats. (1991) (0)
[Anti-GBM glomerulonephritis and RPGN]. (2009) (0)
[Report on 1st Korea-Japan nephrology forum]. (2003) (0)
Contents Vol. 89, 2001 (2001) (0)
Case report: late relapse in a case of mesangioproliferative glomerulonephritis. (1996) (0)
Control of patients with diabetic nephropathy (1995) (0)
Lab methods, progression & risk factors for CKD - 3 (2009) (0)
Detection of immunoglobulin depositions by immunofluorescence and/or immunoperoxidase (P-AP method) in patients with IgA nephropathy. (1987) (0)
[IgA nephropathy]. (2002) (0)
Glomerular deposition of L-ficolin and mannose-binding lectin in a patient with membranous nephropathy: Activation of the lectin complement pathway (2007) (0)
Issues in hereditary angioedema (2011) (0)
Subject Index, Vol. 59, 1991 (1991) (0)
Test method in kidney diseases (2010) (0)
Contents Vol. 81, 1999 (1999) (0)
Opening address on memorial lectures (2007) (0)
Solubilization of intraglomerular deposits of serum proteins by fresh human sera or gamma-globulin in patients with diabetic nephropathy. (1984) (0)
[Molecular mechanisms in renal disease]. (2006) (0)
Clinical Reviews of IgA Nephropathy (2007) (0)
Subject Index Vol. 4, 1993 (1993) (0)
A case of Wegener's granulomatosis showing a dramatic response to corticosteroid and cyclophosphamide therapy--evaluation of anticytoplasmic antibodies (ACPA) in serum samples. (1990) (0)
SUN-319 SOURSOP SUPPLEMENTATION HAS BENEFIT EFFECTS ON BLOOD PRESSURE AND SERUM URIC ACID BUT DOES NOT AFFECT KIDNEY FUNCTIONS AND SERUM POTASSIUM LEVELS: AN RCT STUDY (2019) (0)
Post-Operative Kidney Function Using Deep Hypothermic Circulatory Arrest (DHCA) in Aortic Arch Operation (2022) (0)
Hyperosmolar nonketotic diabetic state associated with disseminated intravascular coagulation and acute renal failure: a case report. (1982) (0)
Subject Index Vol. 83, 1999 (1999) (0)
A Case of Mesangial IgM Renal Nephropathy Function with Decreased (2018) (0)
FP304ABERRANT APRIL EXPRESSION IN TONSILLAR GERMINAL CENTER B CELLS IN IGA NEPHROPATHY PATIENTS (2015) (0)
PS 13-07 IGA NEPHROPATHY IS EXACERBATED BY PREGNANCY AND IS A RISK FACTOR FOR PREECLAMPSIA IN GROUPED DDY MICE (2016) (0)
[Kidney diseases caused by hypercalcemia, hyperuricemia, hyperoxaluria and hypokalemia]. (1994) (0)
Hemodialysis (HD) therapy for 21 years in Juntendo University Hospital : the effects of antihypertensive therapy before starting HD (2001) (0)
[Systemic edema in kidney diseases]. (2005) (0)
Two cases of acute poststreptococcal glomerulonephritis superimposed on rheumatoid arthritis. (1984) (0)
Inhibition of geranylgeranylation suppresses the proliferation of rat cultured mesangial cells (2002) (0)
Preventive Effects of Erythropoietin on Peritoneal Hypoxia and Fibrosis in Rats with Chlorhexidine Gluconate-induced Peritoneal Fibrosis (2011) (0)
Clinical Effect with of Dipyridamole in IgA Nephropathy Patients (2018) (0)
IgA Nephropathy (1987) (0)
Clinical Study Transperitoneal Calcium Balance in Anuric Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients (2015) (0)
Perpetuation of Immune Nephritis Respiratory Burst : Potential Role in the Through an Fc Receptor-Dependent Induce Polymorphonuclear Cell Recruitment Pre-Existing Glomerular Immune Complexes (2003) (0)
Evaluation of zinc replacement therapy for anemia associated with hypozincemia in hemodialysis patients (2020) (0)
RhoA kinase inhibitor, fasudil, protects against crescentic glomerulonephritis via podocyte protection. (2007) (0)
Sl Selective IgM Deficiency : A Case Study (2018) (0)
The Influence of an Unexpected Switch of Hemodialysis Facilities on the Quality of Life (QOL) in Hemodialysis Patients (2022) (0)
Renal insufficiency : With aim of prevention and progress.2.Acute renal insufficiency.2.Nephrosis showing renal insufficiency.Disease state, treatment and prognosis. (1993) (0)
A hemodialysis patient suffering from fever of unknown origin (FUO) associated with a mass in the heart (2002) (0)
Subject Index Vol. 9, 2001 (2001) (0)
The Role of Smad4 in Murine T Cells in Terms of IgA Nephropathy and Potential Mechanism of Glomerular IgA Deposition (2014) (0)
Perforated-peritonitis in 4 patients on continuous ambulatory peritoneal dialysis (CAPD) (1995) (0)
Utility of remission criteria for the renal prognosis of IgA nephropathy (2021) (0)
Mass media information can facilitate early diagnose of hereditary angioedema: Case series study (2018) (0)
Analysis of IgA nephropathy by serial renal biopsies in the ddY mouse: heterogeneous progression of glomerulonephritis (2004) (0)
Inhibitory Effect of Iron Administration on Vascular Calcification in Uremic Rats (2013) (0)
Down-regulation of CD43 molecule expression on the surface of intraperitoneal neutrophils in CAPD peritonitis (1995) (0)
Relationship between factors related to renal osteodystrophy and vascular calcification in CKD patients (2005) (0)
The Role of Podocytes in Renal Diseases (2012) (0)
Author's response to reviews Title:Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage Authors: (2014) (0)
[Urinary type IV collagen]. (1998) (0)
13. Basis and Medical Care of IgA Nephropathy (2008) (0)
Patterns of matrix metalloproteinases and transforming growth factor-beta 1 expression during peritoneal repair in chlorhexidine induced peritoneal fibrosis mice (2012) (0)
Vasculitis and inflammatory cardiovascular diseases (WS-042) Chairpersons: Shoichi Ozaki, Loic Guillevin (2010) (0)
Effects of Dietary Calcium on Erythrocyte Sodium Ion Transport Systems in Spontaneously Hypertensive Rats (1991) (0)
Editorial (2002) (0)
Contents Vol. 91, 2002 (2002) (0)
An AdultCase of Fanconi ' s Membranous Syndrome Associated with Nephropathy (2017) (0)
Announcement / Book Reviews (1999) (0)
Acute Kidney Injury (AKI) and Management of Renal Tumors (2012) (0)
Contents, Vol. 11, 1991 (1991) (0)
Glomerulonephritis Fibrinolytic Activity Protect against Fatal Mast Cell-Mediated Remodeling and (2013) (0)
[Detection of glycosylated protein of renal tissues using NBT reaction in STZ-induced diabetic rats]. (1992) (0)
[Diagnosis of and therapy for IgA nephropathy]. (2004) (0)
[The levels of fibrinopeptide A and fibrinopeptide B beta in the urine from patients with chronic glomerulonephritis during urokinase therapy]. (1985) (0)
Outcomes of the Re-classification of WHO Class IV Lupus Nephritis Using the ISN/RPS Classification: a Single Center Retrospective Observational Study from the JUDE Study (2017) (0)
[Immunohistological studies in IgA nephropathy (author's transl)]. (1980) (0)
Gene polymorphism in the promoter region of lipopolysaccharide receptor CD14 and dyslipidemia in hemodialysis patients. (2003) (0)
Electron microscopic observation of the stellate cells of rabbit's liver upon intravenous administration of polyvinyl acetate. (1961) (0)
DETECTION OF IMMUNOGLOBULINS AND OTHER SERUM PROTEINS IN THE DERMAL AND GLOMERULAR CAPILLARY WALLS FROM PATIENTS WITH DIABETES MELLITUS (1986) (0)
Peroxisome Proliferator-Activated Receptor c Gene Polymorphism is Associated With Serum Triglyceride Levels and Body Mass Index in Japanese Type 2 Diabetic Patients (2004) (0)
Contents / Foreword / Acknowledgments (2007) (0)
124 ANGIOTENSINOGEN M235T GENE POLYMORPHISM IN ESSENTIAL HYPERTENSION AMONG YOGYAKARTA JAVANESE INDONESIANS (2012) (0)
TWEAK/Fn14 system and crescent formation in (2015) (0)
Detection of IgA dominant immune complexes on peripheral blood lymphocytes in patients with IgA nephropathy. (1986) (0)
[Morphological features of red blood cells in urinary sediment from patients with glomerular diseases]. (1985) (0)
Changes of serum IgA /C3 ratio in patients with IgA nephropathy (2008) (0)
The PBL program as a part of the liberal arts curriculum (2008) (0)
Antineutrophil cytoplasmic antibody (ANCA)-associated crescentic glomerulonephritis. (2000) (0)
[Present status and future of dialysis therapy in Asia]. (2004) (0)
Telmisartan and Oxacalcitriol in ADR-Nephropathy Combination Therapy with Telmisartan and Oxacalcitriol Suppresses the Progression of Murine Adriamycin Nephropathy Running title: Telmisartan and oxacalcitriol in ADR-nephropathy (2016) (0)
Preliminary Pages / Contents / Preface (2001) (0)
Editorial (2000) (0)
Role of cytokine mediators in the pathogenesis of IgA nephropathy (2000) (0)
A report of 1150 cases of renal biopsy over 23 years in Juntendo University Hospital (2003) (0)
New Biomarkers for Diagnosis in Patients with Chronic Kidney Disease (CKD) (2015) (0)
(Renal-Ocular Syndrome) A case of tubulo-interstitial nephritis and uveitis syndrome (1990) (0)
[A case of thymic lymphosarcoma (author's transl)]. (1976) (0)
A case of cerebral artery dissection that occurred after the patient washed her face (2011) (0)
IgA nephropathy today: Foreword (2007) (0)
A case of primary aldosteronism with hypokalemia and headache treated by laparoscopic adrenalectomy (2011) (0)
[Diabetic nephropathy]. (2020) (0)
[Goodpasture syndrome]. (2020) (0)
Contents, Vol. 9, 1989 (1989) (0)
Pathogenesis and Treatment of Diabetic Nephropathy (2013) (0)
Contents, Vol. 17, 1994 (1994) (0)
Subject Index Vol. 117, 2011 (2011) (0)
Tensin is expressed in rat glomerular mesangial cells. (2004) (0)
Serum levels of complement regulatory proteins in patients with IgA nephropathy (2007) (0)
[IgA nephropathy (author's transl)]. (1977) (0)
CAPD catheter insertion for prior abdominal surgery patients. (1993) (0)
An autoradiographic analysis of experimental non-oliguric acute renal failure in the mouse. (1985) (0)
Determination of glomerular NAG fraction in urine samples of patients with diabetic nephropathy using the NAG test kit. (1992) (0)
[Epidemiology of diabetic nephropathy]. (2010) (0)
Cold-reacting antinuclear factor in sera from patients with primary glomerular diseases. (1985) (0)
Antigen-Dependent Mechanism of IgA Nephropathy (2009) (0)
A case of hereditary angioedema due to C1-inhibitor deficiency with recurrent abdominal pain diagnosed 40 years after the occurrence of the initial symptom (2021) (0)
Advances in the treatment of chronic glomerulonephritis (1995) (0)
Parameters of altered plasma glucose levels during short intervals in diabetic patients. (1986) (0)
USEFULNESS OF SERUM PROTEINS AS EARLY MARKERS OF GLOMERULAR INJURY IN PATIENTS WITH TYPE 2 DIABETIC NEPHROPATHY (2012) (0)
Molecular weights of IgA-circulating immune complexes (CIC) in patients with IgA nephropathy: application of HPLC and solid-phase anti-C3 Facb EIA. (1988) (0)
Subject Index, Vol. 9, 1989 (1989) (0)
Beyond the Differences in Tonsillectomy in IgA Nephropathy: From Rationale To Indications in Patients (2016) (0)
Two adult cases of ectopic kidney. (1984) (0)
Contents Vol. 117, 2011 (2011) (0)
16. Improvement of peritoneal calcification after parathyroidectomy in a peritoneal dialysis patient(Annual Reports from Division of Biomedical Imaging Research, Biomedical Research Center, Juntendo University Graduate School of Medicine.) (2008) (0)
[The cutting-edge of medicine; the role of podocytes in renal diseases]. (2012) (0)
[An elderly patient with IgD myeloma associated with renal amyloidosis and acute renal failure]. (1989) (0)
Lubiprostone and linaclotide as treatments for chronic constipation in hemodialysis patients at a long‒term care hospital (2021) (0)
Contents Vol. 33, 2011 (2011) (0)
Subject Index, Vol. 54, 1990 (1990) (0)
Clinicopathological Findings of IgA Nephropathy (2015) (0)
A case of primary systemic amyloidosis. (1985) (0)
Correction to: A case of hereditary angioedema due to C1-inhibitor deficiency with recurrent abdominal pain diagnosed 40 years after the occurrence of the initial symptom (2021) (0)
Polyclonal IgA in IgA nephropathy. (1988) (0)
[Evaluation of prognostic features in patients with IgA nephropathy]. (1987) (0)
Subject Index Vol. 91, 2002 (2002) (0)
Genetic factors related to progression of type 2 diabetic nephropathy in Japanese (2003) (0)
Occurrence of Reversible Posterior Leukoencephalopathy Syndrome in a Continuous Ambulatory Peritoneal Dialysis Patient (2013) (0)
1 Sorting Nexin 9 facilitates podocin endocytosis in the injured podocyte 1 2 (2017) (0)
Anti-proteinuric and anti-oxidative effects of a calcium channel blocker; benidipine in elderly hypertensive patients with chronic kidney disease (2011) (0)
Contents Vol. 9, 2001 (2001) (0)
Detection of alpha 2-pregnancy associated-glycoprotein (alpha 2-PAG) in cultured human peripheral blood mononuclear cells. (1986) (0)
Risk factors associated with left ventricular mass index using echocardiography in chronic kidney disease patients Running title: Risk factors for LVMI in CKD patients (2015) (0)
Apoptotic cells in six patients with IgA nephropathy in repeat biopsies (2001) (0)
Subject Index, Vol. 8, 1988 (1988) (0)
Treatment for IgA nephropathy. (2007) (0)
Cut-off value of C1-inhibitor function for the diagnosis of hereditary angioedema due to C1-inhibitor deficiency. (2021) (0)
Subject Index, Vol. 62, 1992 (2004) (0)
[Serum levels of remnant-like particles-cholesterol (RLP-C) in patients on hemodialysis]. (1996) (0)
Contents, Vol. 3, 1983 (1983) (0)
Future Prospects for IgA Nephropathy (1999) (0)
Detection of DNA polymerase-alpha-positive cells in the glomeruli from patients with IgA nephropathy. (1989) (0)
[Pharmakokinetics of hydrophobic drugs: hepatic metabolism and excretion]. (2012) (0)
Acute kidney injury - Experimental models (2011) (0)
Evaluation of the role of a visiting nurse station attached to the outpatient hemodialysis unit (2002) (0)
Levels of fibrinopeptide A (FPA) and fibrinopeptide B beta 15-42 (FPB beta) in urine and plasma after urokinase administration in patients with chronic glomerulonephritis. (1986) (0)
Alport syndrome diagnosed by immunofluorescence using a new monoclonal antibody. (1993) (0)
Controversial Management Strategies for IgA Nephropathy (2013) (0)
[Pathology of diabetic nephropathy]. (2012) (0)
A case of Wegener's granulomatosis showing a dramatic response to corticosteroid and cyclophosphamide therapy (1990) (0)
[Acute renal failure. 2. Nephrosis with symptoms of renal failure--physiopathology, treatment, and prognosis]. (1993) (0)
Increased mRNA expression encoding for medullasin in peripheral blood mononuclear cells from patients with IgA nephropathy. (1993) (0)
Contents, Vol. 47, 1987 (1987) (0)
High D Allele Frequency of ACE I/D Gene Polymorphism in Familial Hypertension in Javanese Indonesian (2012) (0)
Subject Index, Vol. 11, 1991 (1991) (0)
Subject Index Vol. 117, 2011 (2011) (0)
Concomitant use of clopidogrel and proton pump inhibitors may attenuate the prognosis of coronary heart disease in hemodialysis patients (2012) (0)
A Study of Thermal Comfort Reported by Patients and Medical Staff in a Dialysis Room during Autumn and Winter (2012) (0)
Stepwise initiation of peritoneal dialysis using the Moncrief and Popovich technique (2002) (0)
Neurofilament heavy polypeptide protects against reduction in synaptopodin expression and prevents podocyte detachment (2018) (0)
28th Czech Congress of Nephrology / Author Index for Abstracts (2001) (0)
Abstract P122: The Identification Of New Serum Uric Acid Levels Cut-off Point To Prevent Prehypertension And Hypertension Based On Jnc 7 And Acc/aha 2017 Classification: A Cross-sectional Study (2021) (0)
A Case of Rhabdomyosarcoma with Atypical Cells in Ascitic Fluid (1978) (0)
A case report of Henoch-Schoenlein purpura nephritis associated with a postbulbar duodenal ulcer. (1982) (0)
Contents, Vol. 54, 1990 (2004) (0)
Effects of a New Maintenance Fluid Containing Sodium Acetate as the Base Component and Electrolytes during Renal Biopsies in Patients with Chronic Glomerulonephritis (2004) (0)
Dysregulation of hepatic fatty acid metabolism in chronic kidney disease (2013) (0)
Contents, Vol. 8, 1988 (1988) (0)
Erratum to: Pioglitazone attenuates TGF‐β1‐induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator‐activated receptor (PPAR) γ [29 (6) 422–428] (2008) (0)
Usefulness of determining the plasma atrial natriuretic peptide (hANP) level in CAPD patients (1998) (0)
Role of NF-AT Pathway Activation of Renin-Angiotensin System : The Immune Complex Disease Is Linked to Local Susceptibility to T Cell-Mediated Injury in Okumura (2002) (0)
[Properdin, factor H, factor I]. (2010) (0)
[Immunologic tests: Properdin, factor H, factor I]. (2005) (0)
Ischemic Stroke Induces Rapid Renal Oxidative Stress and Lipometabolic Change (2021) (0)
[Case report; A case of hypermagnesemia accompanied with disturbance of consciousness induced by acute kidney injury]. (2012) (0)
Potential role of dendritic cells in murine IgA nephropathy through regulation of B cell growth and differentiation (2007) (0)
Relationship between disease progression and podocyte injury in patients with IgA nephropathy (1999) (0)
[Overview of IgA nephropathy]. (2008) (0)
Accumulative mesangial deposits without renal damage and dysfunction of FcR gamma chain knockout mice (1998) (0)
Peritoneal dialysis (2013) (0)
Asian Reports-Introduction (2003) (0)
Comparative Sediments Studies among Morphological Changes of Urinary and Histopathological Injuries in Patients with IgA Nephropathy (2018) (0)
Subject Index, Vol. 3, 1983 (1983) (0)
[Alteration of polyol metabolism in glomeruli of streptozotocin diabetic rats--analysis by gas chromatography-mass spectrometry]. (1990) (0)
Tensin expression and localization in human renal tissues (2004) (0)
Diagnosis and treatment of patients with IgA nephropathy, one of major causes of chronic kidney disease (CKD), in Japan (2016) (0)
Glomerulonephritis and immunity. (1998) (0)
Geographic and Genetic Features (1999) (0)
pathological Role Of Palatine Tonsil In Iga Nephropathy : sy3–05 (2014) (0)
Glomerulonephritis Prevents the Development of Experimental Signaling in T Cells β Blockade of TGF-Tomino and Chisei (2001) (0)
[Renal excretion of water-soluble drugs]. (2012) (0)
Etiology and Pathogenesis (1999) (0)
Effects of erythropoietin on the peritoneum in chlorhexidine gluconate-induced peritoneal sclerosis rat models (2007) (0)
Transient Thyrotoxicosis After Parathyroidectomy in a Hemodialysis Patient with Secondary Hyperparathyroidism (2007) (0)
A hemodialysis patient suffering from fever of unknown origin associated with inflammatory malignant fibrous histiocytoma (2015) (0)
An Overview of Dialysis Treatment in Juntendo Tokyo Koto Geriatric Medical Center During the First Ten Years of Operation:a Comparison with a Nationwide Statistical Survey in Japan at the End of 2012 (2015) (0)
Contents, Vol. 64,1993 (1993) (0)
Subject Index Vol. 75, 1997 (1997) (0)
[Discrepancy of serum IgA levels measured by single radial immunodiffusion and laser nephelometry in patients with IgA nephropathy]. (1983) (0)
Alternation of Glomerular Eicosanoid Metabolism in Spontaneous Hypertensive Rats (1990) (0)
A case of PD that showed improved peritoneal function by introduction of automated peritoneal dialysis (1999) (0)
A case of IgM-associated mesangial proliferative glomerulonephritis with a giant paramesangial spherical deposit. (1991) (0)
Podocin is translocated to cytoplasm in puromycin aminonucleoside nephrosis rats and in poor-prognosis patients with IgA nephropathy (2015) (0)
Analysis of Renin-Angiotensin-Aldosterone System Gene Polymorphisms in Essential Hypertension in Javanese Indonesian (2015) (0)
Effect of advanced glycation end product receptor signal transduction on MCP-1 expression of podocyte induced by carboxymethyllysine (2005) (0)
A4494 The effect of soursop supplement on blood pressure, serum uric acid and kidney function in prehypertensive patients for more than ten years in javanese population of Indonesia (2018) (0)
[Tubulo-interstitial nephropathy; TIN]. (1997) (0)
[Glomerulonephritis and immunology]. (1998) (0)
[Onset, mechanism of development, and therapy of IgA nephropathy]. (2000) (0)
Some Thoughts from Your Publisher (2002) (0)
Functional expression of FcRn and transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells (2001) (0)
A CASE OF PRIMARY AMYLOIDOSIS WITH RAPIDLY PROGRESSIVE MULTIPLE ORGAN FAILURE (2013) (0)
Icatibant promotes patients' behavior modification associated with emergency room visits during an acute attack of hereditary angioedema. (2021) (0)
Localization of pulmonary surfactant protein D in kidney. (2006) (0)
Contents, Vol. 75, 1997 (1997) (0)
Erratum to: Improvement of rapidly progressive lupus nephritis associated MPO-ANCA with tacrolimus (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Yasuhiko Tomino?

Yasuhiko Tomino is affiliated with the following schools:

Yasuhiko Tomino's Academic­Influence.com Rankings

Yasuhiko Tomino's Degrees

Similar Degrees You Can Earn

Why Is Yasuhiko Tomino Influential?

Yasuhiko Tomino's Published Works

Published Works

What Schools Are Affiliated With Yasuhiko Tomino?

Yasuhiko Tomino's AcademicInfluence.com Rankings